Literature DB >> 26629160

Regulation of macrophage cholesterol efflux and liver X receptor α activation by nicotine.

Hongming Zhang1, Xiaoyan Li1, Zongjie Qian2.   

Abstract

OBJECTIVE: This study aims to investigate the characteristics of liver X receptor α (LXRα) and its target gene expression, as well as cholesterol efflux in human macrophages treated by nicotine.
METHODS: Human monocyte-derived macrophages were collected. Before apoA-I-mediated human monocyte-derived macrophage cholesterol efflux, and mRNA expression of LXRα, and some of its target genes being detected, the macrophages were induced with or without nicotine.
RESULTS: Pre-incubation of Human monocyte-derived macrophages with nicotine, cholesterol efflux was suppressed to apolipoprotein AI. Nicotine also inhibited LXRα and some of its target genes mRNA expression involved cholesterol metabolism, and facilitated some inflammatory genes expression.
CONCLUSION: The changed function of cholesterol efflux and some genes expression may be the pathogenetic cause, and LXR activity of macrophage may offer potential therapeutic benefit in the treatment of atherosclerosis. Thus nicotine can regulate foam cell formation by inhibiting LXR pathway.

Entities:  

Keywords:  Nicotine; cholesterol efflux; human monocyte-derived macrophage; liver X receptor

Year:  2015        PMID: 26629160      PMCID: PMC4659048     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

Review 1.  High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

Authors:  A von Eckardstein; J R Nofer; G Assmann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

2.  Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis.

Authors:  C Heeschen; J J Jang; M Weis; A Pathak; S Kaji; R S Hu; P S Tsao; F L Johnson; J P Cooke
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

3.  Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice.

Authors:  Paul P Lau; Lan Li; Aksam J Merched; Alan L Zhang; Kerry W S Ko; Lawrence Chan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-27       Impact factor: 8.311

4.  [Study on the correlation between Chinese medical syndrome types and serum levels of PLTP and CETP in coronary heart disease patients].

Authors:  Ping-ting Zhu; Ping Bo; Yun Sun
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2011-06

5.  Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux.

Authors:  Guorong Lin; Karin E Bornfeldt
Journal:  Biochem Biophys Res Commun       Date:  2002-01-18       Impact factor: 3.575

Review 6.  Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.

Authors:  Mercedes Ricote; Annabel F Valledor; Christopher K Glass
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-30       Impact factor: 8.311

7.  Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism.

Authors:  Shogo Suzuki; Tomoko Nishimaki-Mogami; Norimasa Tamehiro; Kazuhide Inoue; Reijiro Arakawa; Sumiko Abe-Dohmae; Arowu R Tanaka; Kazumitsu Ueda; Shinji Yokoyama
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-15       Impact factor: 8.311

8.  Nicotine induced changes in gene expression by human coronary artery endothelial cells.

Authors:  S Zhang; I Day; S Ye
Journal:  Atherosclerosis       Date:  2001-02-01       Impact factor: 5.162

9.  Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions.

Authors:  Alexandra Aicher; Christopher Heeschen; Mariette Mohaupt; John P Cooke; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

10.  Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.

Authors:  Nancy Levin; Eric D Bischoff; Chris L Daige; Diane Thomas; Calvin T Vu; Richard A Heyman; Rajendra K Tangirala; Ira G Schulman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-11       Impact factor: 8.311

  10 in total
  2 in total

1.  The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot .

Authors:  Pavel Mucaji; Atanas G Atanasov; Andrzej Bak; Violetta Kozik; Karolina Sieron; Mark Olsen; Weidong Pan; Yazhou Liu; Shengchao Hu; Junjie Lan; Norbert Haider; Robert Musiol; Jan Vanco; Marc Diederich; Seungwon Ji; Jan Zitko; Dongdong Wang; Danica Agbaba; Katarina Nikolic; Slavica Oljacic; Jelica Vucicevic; Daniela Jezova; Anna Tsantili-Kakoulidou; Fotios Tsopelas; Constantinos Giaginis; Teresa Kowalska; Mieczyslaw Sajewicz; Jerzy Silberring; Przemyslaw Mielczarek; Marek Smoluch; Izabela Jendrzejewska; Jaroslaw Polanski; Josef Jampilek
Journal:  Molecules       Date:  2017-10-28       Impact factor: 4.411

Review 2.  Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.

Authors:  Dmitry Y Litvinov; Eugeny V Savushkin; Alexander D Dergunov
Journal:  Pharmaceut Med       Date:  2019-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.